| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/27/2011 | US20110020367 Methods of Evaluating Transplant Rejection |
| 01/27/2011 | US20110020365 Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma |
| 01/27/2011 | US20110020357 Anti human immunodeficiency antibodies and uses thereof |
| 01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020333 Angiogenesis Pathway Gene Polymorphisms for Therapy Selection |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020317 Breast tumour grading |
| 01/27/2011 | US20110020314 Identifying haematopoietic stem cells based on cell surface markers |
| 01/27/2011 | US20110020293 Use of Stem Cells to Reduce Leukocyte Extravasation |
| 01/27/2011 | US20110020292 Use of Stem Cells to Reduce Leukocyte Extravasation |
| 01/27/2011 | US20110020286 Trichoderma atroviride sc1 for biocontrol of fungal diseases in plants |
| 01/27/2011 | US20110020267 Tweak receptor |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020233 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof |
| 01/27/2011 | US20110020230 Biomarkers for prostate cancer |
| 01/27/2011 | US20110020216 Scaffolds for cell collection or elimination |
| 01/27/2011 | US20110017595 Biosensor Membranes Composed of Polymers Containing Heterocyclic Nitrogens |
| 01/27/2011 | DE102008025992B4 Titerplatte und Verfahren zur Detektion eines Analyten Titer plate and method for detecting an analyte |
| 01/27/2011 | CA2768794A1 Sequences and their use for detection and characterization of e. coli o157:h7 |
| 01/27/2011 | CA2768735A1 Testing of biofilm for anti-microbial agent susceptibility |
| 01/27/2011 | CA2768711A1 Gene expression markers for crohn's disease |
| 01/27/2011 | CA2768699A1 Method and kit for detection of live microorganisms |
| 01/27/2011 | CA2768667A1 Analyzing the fmr1 gene |
| 01/27/2011 | CA2768617A1 Flow cell device |
| 01/27/2011 | CA2768593A1 A method of removing nucleic acid contamination in reverse transcription and amplification reactions |
| 01/27/2011 | CA2768576A1 Use of stem cells to reduce leukocyte extravasation |
| 01/27/2011 | CA2768573A1 Use of stem cells to reduce leukocyte extravasation |
| 01/27/2011 | CA2768391A1 Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range |
| 01/27/2011 | CA2768373A1 Heteroaryl benzamides, compositions and methods of use |
| 01/27/2011 | CA2768301A1 Universal microbial diagnosis, detection, quantification, and specimen-targeted therapy |
| 01/27/2011 | CA2768042A1 Raf dimers and uses thereof |
| 01/27/2011 | CA2767914A1 Markers for endometrial cancer |
| 01/26/2011 | EP2278317A1 Field effect transistor device for ultra-fast nucleic acid sequencing |
| 01/26/2011 | EP2278315A1 Analyte test strip having predetermined calibration characteristics |
| 01/26/2011 | EP2278313A1 Electrodes, methods, apparatuses comprising micro-electrode arrays |
| 01/26/2011 | EP2278303A2 Method and system for multiplex genetic analysis |
| 01/26/2011 | EP2278030A2 Methods for the survey and genetic analysis of populations |
| 01/26/2011 | EP2278029A2 Methods for the survey and genetic analysis of populations |
| 01/26/2011 | EP2278028A1 Method for diagnosing non-small cell lung cancers |
| 01/26/2011 | EP2278027A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 01/26/2011 | EP2278026A1 A method for predicting clinical outcome of patients with breast carcinoma |
| 01/26/2011 | EP2278025A1 Method for evaluation of degree of malignancy of tumor cell |
| 01/26/2011 | EP2278024A1 Epitope cluster from NY-ESO-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278023A1 Epitope cluster from Melan-A/MART-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278015A1 Method of producing a carbohydrate ester |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278011A2 Neisseria meningitidis antigens |
| 01/26/2011 | EP2278010A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278009A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278008A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278007A1 Conserved neisserial antigens |
| 01/26/2011 | EP2278006A2 Neisserial antigens |
| 01/26/2011 | EP2278005A2 Fuctional and hyperfunctional sirna |
| 01/26/2011 | EP2277991A1 Method and quantification assay for determining c-kit/SCF/pAKT status |
| 01/26/2011 | EP2277907A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277906A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277905A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277904A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277903A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277902A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277901A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277893A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277892A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277873A1 Intermediate compound for the preparation of halichondrin analogs |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277532A1 Novel composition and methods for the treatment of immune related diseases |
| 01/26/2011 | EP2277528A2 Use of VEGF and homologues to treat neuron disorders |
| 01/26/2011 | EP2277522A2 Methods for increasing or decreasing bone density and identifying molecules |
| 01/26/2011 | EP2277032A1 A molecule detecting system |
| 01/26/2011 | EP2276861A1 Method for analysing the epigenetic status of the htra 1 gene in a biological sample |
| 01/26/2011 | EP2276860A1 Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule |
| 01/26/2011 | EP2276859A1 Detection of pcr products in gel electrophoresis |
| 01/26/2011 | EP2276858A2 Restriction endonuclease enhanced polymorphic sequence detection |
| 01/26/2011 | EP2276857A1 Impaired alleles of genes involved in metabolic pathways and methods for detecting and using the same |
| 01/26/2011 | EP2276856A1 Identification of orthologous genes |
| 01/26/2011 | EP2276855A2 Genetic polymorphisms associated wiith venous thrombosis, methods of detection and uses thereof |
| 01/26/2011 | EP2276854A1 Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 01/26/2011 | EP2276853A2 Electrochemical labels derived from siderophores |
| 01/26/2011 | EP2276852A2 Phage-mediated bioluminescent detection of yersinia pestis |
| 01/26/2011 | EP2276849A1 Analysis of nucleic acid amplification curves using wavelet transformation |
| 01/26/2011 | EP2276570A1 Microfluidic chip devices and their use |
| 01/26/2011 | EP2276569A1 Kit for collecting blood, preferably peripheral blood, for the production of stem cells |
| 01/26/2011 | EP2035584B1 Nanosensors and related technologies |
| 01/26/2011 | EP1951897B1 Chromosomal analysis by molecular karyotyping |
| 01/26/2011 | EP1885882B1 Methods of mapping polymorphisms and polymorphism microarrays |
| 01/26/2011 | EP1881068B1 Primers, probes, methods and uses thereof for the detection of mycobacterium kansasii |
| 01/26/2011 | EP1878801B1 Protein cleavage method and use thereof |
| 01/26/2011 | EP1781786B1 Method of error reduction in nucleic acid populations |
| 01/26/2011 | EP1737945B1 Method for purifying plasmid dna |
| 01/26/2011 | EP1581649B1 Binding agents which inhibit myostatin |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1506313B1 Methods of screening for modulators of the mitochondrial NAD-dependent deacetylase SIRT3 |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | EP1349954B1 Materials and methods for detection of nucleic acids |
| 01/26/2011 | EP1261621B1 Phosphorylation assays |
| 01/26/2011 | EP0951552B1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/26/2011 | EP0948625B1 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 01/26/2011 | EP0946725B1 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |